Evidence map›Paper›PMID 21999375›Full record

ArticleJournal of neuroinflammation2011

LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.

Keri B Vartanian, Susan L Stevens, Brenda J Marsh, Rebecca Williams-Karnesky, Nikola S Lessov, Mary P Stenzel-Poore

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 2 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Repetitive Administration of Low-Dose Lipopolysaccharide Improves Repeated Social Defeat Stress-Induced Behavioral Abnormalities and Aberrant Immune Response.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Bioinformatic identification of hub genesFrontiers in neuroscience · 2023
    Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Keri B VartanianDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, 97239, USA.
Susan L Stevens
Brenda J Marsh
Rebecca Williams-Karnesky
Nikola S Lessov
Mary P Stenzel-Poore
Oregon Health & Science University · US

Funding

Molecular Mechanisms of LPS Preconditioning In StrokeR01NS050567 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI STENZEL-POORE, MARY P · 2005 to 2015
$3.3M
Toll-like Receptors: Novel targets of neuroprotection in ischemic brain injuryR01NS062381 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI STENZEL-POORE, MARY P · 2009 to 2013
$1.8M
Blood genomics and proteomics of CpG-induced neuroprotection in primate stroke.F30NS070359 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, REBECCA LYNN · 2010 to 2014
$220k
NINDS NIH HHS F30 NS070359NINDS NIH HHS R01 NS050567NINDS NIH HHS R01 NS062381
6 · The paper itself

Abstract

backgroundToll-like receptor 4 (TLR4) is activated in response to cerebral ischemia leading to substantial brain damage. In contrast, mild activation of TLR4 by preconditioning with low dose exposure to lipopolysaccharide (LPS) prior to cerebral ischemia dramatically improves outcome by reprogramming the signaling response to injury. This suggests that TLR4 signaling can be altered to induce an endogenously neuroprotective phenotype. However, the TLR4 signaling events involved in this neuroprotective response are poorly understood. Here we define several molecular mediators of the primary signaling cascades induced by LPS preconditioning that give rise to the reprogrammed response to cerebral ischemia and confer the neuroprotective phenotype.

methodsC57BL6 mice were preconditioned with low dose LPS prior to transient middle cerebral artery occlusion (MCAO). Cortical tissue and blood were collected following MCAO. Microarray and qtPCR were performed to analyze gene expression associated with TLR4 signaling. EMSA and DNA binding ELISA were used to evaluate NFκB and IRF3 activity. Protein expression was determined using Western blot or ELISA. MyD88-/- and TRIF-/- mice were utilized to evaluate signaling in LPS preconditioning-induced neuroprotection.

resultsGene expression analyses revealed that LPS preconditioning resulted in a marked upregulation of anti-inflammatory/type I IFN-associated genes following ischemia while pro-inflammatory genes induced following ischemia were present but not differentially modulated by LPS. Interestingly, although expression of pro-inflammatory genes was observed, there was decreased activity of NFκB p65 and increased presence of NFκB inhibitors, including Ship1, Tollip, and p105, in LPS-preconditioned mice following stroke. In contrast, IRF3 activity was enhanced in LPS-preconditioned mice following stroke. TRIF and MyD88 deficient mice revealed that neuroprotection induced by LPS depends on TLR4 signaling via TRIF, which activates IRF3, but does not depend on MyD88 signaling.

conclusionOur results characterize several critical mediators of the TLR4 signaling events associated with neuroprotection. LPS preconditioning redirects TLR4 signaling in response to stroke through suppression of NFκB activity, enhanced IRF3 activity, and increased anti-inflammatory/type I IFN gene expression. Interestingly, this protective phenotype does not require the suppression of pro-inflammatory mediators. Furthermore, our results highlight a critical role for TRIF-IRF3 signaling as the governing mechanism in the neuroprotective response to stroke.

Indexed as

Brain IschemiaIschemic PreconditioningSignal TransductionStrokeAdaptor Proteins, Vesicular TransportAnimalsChemokinesCytokinesGene Expression ProfilingHumansInfarction, Middle Cerebral ArteryInterferon Regulatory Factor-3LipopolysaccharidesMaleMiceMice, Inbred C57BLAdaptor Proteins, Vesicular TransportChemokinesCytokinesInterferon Regulatory Factor-3Irf3 protein, mouseLipopolysaccharidesNF-kappa BTicam1 protein, mouseToll-Like Receptor 4

Identifiers

PMID21999375
PMCPMC3217906
OpenAlexW2145431360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.